When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZGNX - FDA rejects Zogenix application for Dravet med Fintepla
Zogenix Inc.
The FDA has issued a Refusal to File (RTF) letter to Zogenix (NASDAQ:ZGNX) related to its marketing application seeking approval for FINTEPLA (fenfluramine hydrochloride) for the treatment of seizures associated with a rare and severe form of epilepsy called Dravet syndrome.
More news on: Zogenix, Inc., Healthcare stocks news, Stocks on the move,